Clinical Trial Update: Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 Years [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 study to evaluate a three-dose vaccination regimen using ascending dose levels of a Clostridioides difficile vaccine, with or without…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Pfizer Clostridioides difficile vaccine

Snippet

Sponsor: Pfizer | Conditions: Clostridium Difficile Associated Disease | Phase 1 | Status: COMPLETED